{
    "Trade/Device Name(s)": [
        "Xpert BCR-ABL Ultra",
        "GeneXpert Dx System",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80 Systems"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K190076",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN160003"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OYX",
        "OOI"
    ],
    "Summary Letter Date": "August 15, 2019",
    "Summary Letter Received Date": "August 19, 2019",
    "Submission Date": "September 24, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.6060",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "BCR-ABL quantitation test",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "BCR-ABL1",
        "ABL1"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80 Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time RT-qPCR",
        "Reverse transcription quantitative polymerase chain reaction",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "RT-qPCR",
        "Molecular quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Cartridge",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Xpert BCR-ABL Ultra RT-qPCR assay for quantitation of BCR-ABL1 and ABL1 mRNA in CML patients on GeneXpert systems",
    "Indications for Use Summary": "For quantitation of BCR-ABL1 and ABL1 mRNA transcripts in peripheral blood from diagnosed t(9;22) positive Chronic Myeloid Leukemia (CML) patients expressing BCR-ABL1 fusion transcripts e13a2 and/or e14a2, to monitor treatment with Tyrosine Kinase Inhibitors (TKIs), not for diagnosis of CML",
    "fda_folder": "Molecular Genetics"
}